(2007). Cole ST: Genome plasticity of BCG and impact on vaccine efficacy. Proc Natl Acad Sci USA
(1999). Cole ST: Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays. Mol Microbiol
(2001). Cole ST: The evolution of mycobacterial pathogenicity: clues from comparative genomics. Trends Microbiol
(2001). DB: Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med
(1999). Decreased capacity of recombinant 45/47-kDa molecules (Apa) of Mycobacterium tuberculosis to stimulate T lymphocyte responses related to changes in their mannosylation pattern.
(1988). Ehrhardt W: Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G250 and R-250. Electrophoresis
(2006). Enhanced patient serum immunoreactivity to recombinant Mycobacterium tuberculosis CFP32 produced in the yeast Pichia pastoris compared to Escherichia coli and its potential for serodiagnosis of tuberculosis.
(2006). Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet
(1994). F: Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA
(2002). F: The diversity of acetylated proteins.
(2002). Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun
(2006). FD: Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatis.
(1992). FM: Immunization of mice with mycobacterial culture filtrate proteins. Clin Exp Immunol
(2009). Functional genomics reveals extended roles of the Mycobacterium tuberculosis stress response factor sigmaH.
(2009). Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCGprimed immunity against Mycobacterium tuberculosis in mice. Vaccine
(2006). Global epidemiology of tuberculosis. Lancet
(2007). HG: Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics
(2008). HG: High accuracy mass spectrometry analysis as a tool to verify and improve gene annotation using Mycobacterium tuberculosis as an example.
(2008). HG: Membrane and membrane-associated proteins in Triton X-114 extracts of Mycobacterium bovis BCG identified using a combination of gel-based and gel-free fractionation strategies. Proteomics
(2001). High extracellular levels of Mycobacterium tuberculosis glutamine synthetase and superoxide dismutase in actively growing cultures are due to high expression and extracellular stability rather than to a protein-specific export mechanism. Infect Immun
(2000). High resolution electroelution of polyacrylamide gels for the purification of single proteins from Mycobacterium tuberculosis culture filtrate.
(1995). Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis. Infect Immun
(2007). Huygen K: Immunogenicity of eight dormancy regulonencoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun
Identification of a novel cytotoxic T lymphocyte epitope from CFP21, a secreted protein of Mycobacterium tuberculosis. Immunol Lett .
(2009). Immunization W-EPo: WHO vaccine-preventable diseases:monitoring system -
(2004). Immunomodulatory action of mycobacterial secretory proteins. Microbes Infect
(2006). In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc
(1991). Isolation and partial characterization of major protein antigens in the culture fluid of Mycobacterium tuberculosis. Infect Immun
(2004). Jungblut PR: CFP10 discriminates between nonacetylated and acetylated ESAT-6 of Mycobacterium tuberculosis by differential interaction. Proteomics
(2003). Kaufmann SH: Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis
(2001). Liberation of soluble proteins from live and dead mycobacterial cells and the implications for pathogenicity of tubercle bacilli hypothesis.
(2006). Lopez-Vidal Y: Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis. Infect Immun
(2009). Lopez-Vidal Y: Phenotypic differences between BCG vaccines at the proteome level. Tuberculosis (Edinb)
LopezVidal Y: The secretome of a recombinant BCG substrain reveals differences in hypothetical proteins.
(2004). Manson SR: Asparagine deamidation: a regulatory hourglass. Mech Ageing Dev
(2000). Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection. Electrophoresis
(2009). Mapping the global use of different BCG vaccine strains. Tuberculosis (Edinb)
(1993). Marchal G: Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infect Immun
(2007). ML: Long lasting BCG protection against leprosy. Vaccine
(1997). ML: Molecular cloning, purification, and serological characterization of MPT63, a novel antigen secreted by Mycobacterium tuberculosis. Infect Immun
(2001). Novel monoclonal antibodies against major antigens of Mycobacterium bovis.
(2009). Onozaki K: Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette-Guerin (BCG) substrains. FEMS Immunol Med Microbiol
(2007). Pevzner PA: Whole proteome analysis of post-translational modifications: applications of mass-spectrometry for proteogenomic annotation. Genome Res
(1999). PM: Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science
(2009). Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Vaccine
(2005). Proteomics-based consensus prediction of protein retention in a bacterial membrane. Proteomics
(2005). Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK. Mol Microbiol
(2009). REPORT Global Tuberculosis control Brazil. World Health Organization;
(2009). RW: Mycobacterium tuberculosis Cpn60.2 and DnaK are located on the bacterial surface, where Cpn60.2 facilitates efficient bacterial association with macrophages. Infect Immun
(1975). SM: N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci USA
(2001). Sonnhammer EL: Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes.
(2009). Systematic genetic nomenclature for type VII secretion systems. PLoS Pathog
(2004). Tascon RE: A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice. Infect Immun
(2007). The Mycobacterium tuberculosis cellsurface glycoprotein apa as a potential adhesin to colonize target cells via the innate immune system pulmonary C-type lectin surfactant protein A. J Biol Chem
(2005). TM: The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol
(2000). Towards the proteome of Mycobacterium tuberculosis. Electrophoresis
(2005). Translation elongation factor EF-Tu is a target for Stp, a serine-threonine phosphatase involved in virulence of Listeria monocytogenes. Mol Microbiol
(1976). Tuberculin sensitivity in guinea-pigs after vaccination with varying doses
(2008). Tuberculosis Control, Surveillance, Planning, Financing. Geneva: World Health Organization;
(2007). Type VII secretion– mycobacteria show the way. Nat Rev Microbiol
(2008). Wang HH: Evaluation of a new recombinant BCG which contains mycobacterial antigen ag85B-mpt64(190-198)-mtb8.4 in C57/BL6 mice.